Wednesday, July 8, 2026

pharma · Metastatic Solid Tumor · Advanced or Metastatic Solid Tumors · HOWL

Werewolf Therapeutics

Werewolf Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Milton, GB HQ
2017 Founded
53 Employees
Public company Type
HOWL · NYSE Ticker
Company details
Status
Public
HQ
Milton, GB
Founded
2017
Employees
53
Programs
2
Drugs
0
Patents
10
Intelligence · Drug Pipeline

Werewolf Therapeutics pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Werewolf Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →